Loss of Mitochondrial Sirt3, Decreased MnSOD Activity, and IR Induced Genomic Instability
线粒体 Sirt3 缺失、MnSOD 活性降低和 IR 诱导的基因组不稳定
基本信息
- 批准号:9440346
- 负责人:
- 金额:$ 36.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-07 至 2020-03-31
- 项目状态:已结题
- 来源:
- 关键词:ARNTL geneAcetylationAddressAffectAgingApoptosisBindingBiochemicalBioenergeticsBiological AvailabilityBrainBreastCancer PatientCell DeathCell ProliferationCell RespirationCellsChemical AgentsCircadian RhythmsClock proteinCytotoxic ChemotherapyDataDeacetylationDetoxification ProcessDevelopmentDrug Metabolic DetoxicationExhibitsFeedbackFundingGene DeletionGenerationsGenesGeneticGenetic TranscriptionGenomeGenomic InstabilityGenotoxic StressGlycolysisHourHumanIn VitroInvestigationIonizing radiationKnockout MiceKnowledgeLaboratoriesLinkLongevityLysineMalignant NeoplasmsMammalian CellMediatingMetabolicMetabolismMitochondriaMitochondrial ProteinsMolecularMusMutant Strains MiceOncogenicOrangesOrganismPathway interactionsPeriodicityPhenotypePlayPredispositionPreventionProcessProdrugsProductionProtein AcetylationProteinsRadiation induced damageReactive Oxygen SpeciesRegulationResearchResearch ProposalsRespirationRodentRoleSOD2 geneScienceSignal TransductionSubgroupSupplementationTestingTherapeuticTissuesTranscription Repressor/CorepressorTranslationsWorkXenograft procedureanticancer researchbasebiological adaptation to stresscancer therapycarcinogenesiscircadian pacemakercytotoxiccytotoxicitydesignhonokiolin vivoinnovationmitochondrial metabolismmouse modelneoplastic cellpersonalized cancer therapypreventpublic health relevanceresponsetumortumorigenesistumorigenic
项目摘要
DESCRIPTION (provided by applicant): One idea of personalized cancer therapy is to identify specific subgroups of cancer patients that will benefit from specific therapeutic strategies. Recently, the NCI has proposed a new research emphasis to design rigorous and innovative research strategies to solve specific problems and paradoxes in cancer research. This research proposal addresses an NCI emphasis: that is how do the proteins that direct life span, at least in some part, affect the molecular mechanisms of cancer development. In addition, can a greater understanding of the mechanisms that direct aging be used to enhance the prevention and/or treatment of cancer? In this regard, it is proposed that the CLOCK/NAD+/SIRT3 axis plays a role in the prevention of damage for IR the deletion of the genes in the axis in mice should result in the creation of new murine models for the investigation of human illness, including human malignancies, that have a strong genetic connection to aging or the genes in the CLOCK/NAD+/SIRT3 axis. In this regard, our preliminary results suggest that circadian CLOCK proteins coordinate mitochondrial metabolism, in part via the modulation of protein acetylation, including MnSOD, to metabolic and oxidative pathways with circadian rhythms. Based on our results, and those or others, it is hypothesized that the CLOCK/NAD+/SIRT3 signaling axis protects against IR-induced damage, cytotoxicity, genomic instability, and carcinogenesis, through the regulation of MnSOD mitochondrial detoxification activity via deacetylation of K68 and K122. In addition, it is proposed that this axis is a potentil molecular axis to sensitize tumor cells to cytotoxic strategies, including IR.
描述(由申请人提供):个性化癌症治疗的一个想法是确定将从特定治疗策略中受益的特定癌症患者亚群。最近,NCI 提出了一个新的研究重点,旨在设计严格和创新的研究策略来解决这一问题。癌症研究中的具体问题和悖论影响了 NCI 的重点:即指导寿命的蛋白质(至少在某种程度上)如何影响癌症发展的分子机制。直接衰老的机制可用于增强预防和/或治疗癌症?在这方面,有人提出CLOCK/NAD+/SIRT3轴在IR损伤中发挥作用,在小鼠中删除预防轴中的基因应该会导致产生用于研究人类疾病(包括人类恶性肿瘤)的新小鼠模型,这些疾病与衰老或 CLOCK/NAD+/SIRT3 轴中的基因有很强的遗传联系。在这方面,我们的初步结果表明昼夜节律 CLOCK 蛋白进行协调。线粒体代谢,部分通过调节蛋白质乙酰化(包括 MnSOD)来调节具有昼夜节律的代谢和氧化途径。通过 K68 和 MnSOD 脱乙酰化调节 MnSOD 线粒体解毒活性,诱导损伤、细胞毒性、基因组不稳定性和致癌作用此外,有人提出该轴是使肿瘤细胞对细胞毒性策略(包括 IR)敏感的潜在分子轴。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Gius其他文献
David Gius的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Gius', 18)}}的其他基金
Lineage Plasticity, due to Disruption of MnSOD Biology, drives resistance to Ionizing Radiation / Androgen Deprivation Therapy
由于 MnSOD 生物学的破坏,谱系可塑性驱动了对电离辐射/雄激素剥夺疗法的抵抗
- 批准号:
10737810 - 财政年份:2021
- 资助金额:
$ 36.13万 - 项目类别:
Lineage Plasticity, due to Disruption of MnSOD Biology, drives resistance to Ionizing Radiation / Androgen Deprivation Therapy
由于 MnSOD 生物学的破坏,谱系可塑性驱动了对电离辐射/雄激素剥夺疗法的抵抗
- 批准号:
10533472 - 财政年份:2021
- 资助金额:
$ 36.13万 - 项目类别:
Lineage Plasticity, due to Disruption of MnSOD Biology, drives resistance to Ionizing Radiation / Androgen Deprivation Therapy
由于 MnSOD 生物学的破坏,谱系可塑性驱动了对电离辐射/雄激素剥夺疗法的抵抗
- 批准号:
10390451 - 财政年份:2021
- 资助金额:
$ 36.13万 - 项目类别:
MnSOD-K68-Ac reprograms a lineage plasticity switch / stemness in ER+ breast malignancies
MnSOD-K68-Ac 重新编程 ER 乳腺恶性肿瘤中的谱系可塑性开关/干性
- 批准号:
10327336 - 财政年份:2021
- 资助金额:
$ 36.13万 - 项目类别:
MnSOD-K68-Ac reprograms a lineage plasticity switch / stemness in ER+ breast malignancies.
MnSOD-K68-Ac 重新编程 ER 乳腺恶性肿瘤中的谱系可塑性开关/干性。
- 批准号:
10817556 - 财政年份:2021
- 资助金额:
$ 36.13万 - 项目类别:
Dys-regulation of the MnSOD-Ac-ROS-HIF2a axis promotes IR / Cisplatin resistance phenotype
MnSOD-Ac-ROS-HIF2a 轴的失调促进 IR/顺铂耐药表型
- 批准号:
10335424 - 财政年份:2021
- 资助金额:
$ 36.13万 - 项目类别:
MnSOD-K68-Ac reprograms a lineage plasticity switch / stemness in ER+ breast malignancies
MnSOD-K68-Ac 重新编程 ER 乳腺恶性肿瘤中的谱系可塑性开关/干性
- 批准号:
10541193 - 财政年份:2021
- 资助金额:
$ 36.13万 - 项目类别:
Lineage Plasticity, due to Disruption of MnSOD Biology, drives resistance to Ionizing Radiation / Androgen Deprivation Therapy
由于 MnSOD 生物学的破坏,谱系可塑性驱动了对电离辐射/雄激素剥夺疗法的抵抗
- 批准号:
10548835 - 财政年份:2021
- 资助金额:
$ 36.13万 - 项目类别:
Dys-regulation of the MnSOD-Ac-ROS-HIF2a axis promotes IR / Cisplatin resistance phenotype
MnSOD-Ac-ROS-HIF2a 轴的失调促进 IR/顺铂耐药表型
- 批准号:
10024964 - 财政年份:2017
- 资助金额:
$ 36.13万 - 项目类别:
Dys-regulation of the MnSOD-Ac-ROS-HIF2a axis promotes IR / Cisplatin resistance phenotype
MnSOD-Ac-ROS-HIF2a 轴的失调促进 IR/顺铂耐药表型
- 批准号:
9889066 - 财政年份:2017
- 资助金额:
$ 36.13万 - 项目类别:
相似国自然基金
ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
- 批准号:82370084
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
高糖水平通过JUN乙酰化修饰上调NCAPD3促进结直肠癌发生的分子机制
- 批准号:82303250
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
β-羟基丁酸介导NF-kB p65去乙酰化修饰在经腹功能性磁刺激治疗脊髓损伤后神经病理性疼痛中的机制研究
- 批准号:82302862
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于ChREBP乙酰化介导脂肪酸代谢探讨“肝病及心”理论内涵及降脂消斑方干预研究
- 批准号:82374192
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
DEPDC5蛋白乙酰化修饰导致mTROC1的激活并促进骨肉瘤的恶性进展
- 批准号:82360472
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Role of skeletal muscle IPMK in nutrient metabolism and exercise
骨骼肌IPMK在营养代谢和运动中的作用
- 批准号:
10639073 - 财政年份:2023
- 资助金额:
$ 36.13万 - 项目类别:
Delineating mechanisms underlying the enhanced stability and functionality of CD2-KO Tregs and chimeric antigen receptor (CAR) Tregs and their application in xenotransplantation
描述 CD2-KO Tregs 和嵌合抗原受体 (CAR) Tregs 稳定性和功能增强的机制及其在异种移植中的应用
- 批准号:
10646753 - 财政年份:2023
- 资助金额:
$ 36.13万 - 项目类别:
Investigating HDAC3 phosphorylation as an epigenetic regulator of memory formation in the adult and aging brain
研究 HDAC3 磷酸化作为成人和衰老大脑记忆形成的表观遗传调节剂
- 批准号:
10752404 - 财政年份:2023
- 资助金额:
$ 36.13万 - 项目类别:
Pilot Studies of PAX3-FOXO1 Fusions Proteins in Alveolar Rhabdomyosarcoma
PAX3-FOXO1 融合蛋白在肺泡横纹肌肉瘤中的初步研究
- 批准号:
10726763 - 财政年份:2023
- 资助金额:
$ 36.13万 - 项目类别: